Letter to the Editor
HAc40 is a novel microbiome modulator, effective on atopic dermatitis in children: data from two pilot vehicle-controlled trials
R. Sacchetti, G. Gregori, E. Moggio, L. Gobbo, L. Bonzano, G Pellacani
First published: 01 June 2021 https://doi.org/10.1111/jdv.17431
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/jdv.17431
Abstract
Microbial balance is fundamental to healthy skin and changes in this ecosystem may lead to several diseases.1 Atopic dermatitis (AD) is associated with altered skin microbiome, prevalence of S. aureus colonization and secondary infections.2,3 Due to prevalence of microbial resistance, antibiotics usage for treating AD has been discouraged4 and several attempts have been conducted to restore a microbiome balance through skin bacteria replacement.5
R. Sacchetti, G. Gregori, E. Moggio, L. Gobbo, L. Bonzano, G Pellacani
First published: 01 June 2021 https://doi.org/10.1111/jdv.17431
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/jdv.17431
Abstract
Microbial balance is fundamental to healthy skin and changes in this ecosystem may lead to several diseases.1 Atopic dermatitis (AD) is associated with altered skin microbiome, prevalence of S. aureus colonization and secondary infections.2,3 Due to prevalence of microbial resistance, antibiotics usage for treating AD has been discouraged4 and several attempts have been conducted to restore a microbiome balance through skin bacteria replacement.5